We are live on ! Find out more
IEIH

iShares Evolved U.S. Innovative Healthcare ETF
IEIH

Delisted

IEIH was delisted on the 22nd of August, 2022.

Back to rankings

2 hedge funds and large institutions have $3.18M invested in iShares Evolved U.S. Innovative Healthcare ETF in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

23% less capital invested

Capital invested by funds: $4.11M → $3.18M (-$929K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$25

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$377K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$3.18M -$377K -15,000 -10%
Fidelity Investments
2
Fidelity Investments
Massachusetts
– +$25 +1 New

IEIH Hedge Fund Activity: Q4 2018 in Review

2 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in iShares Evolved U.S. Innovative Healthcare ETF (IEIH) for Q4 2018, worth a combined $3.18M — down 23% from $4.11M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new IEIH positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $25. The largest seller was BlackRock, cutting an estimated $377K.

  • 2 institutional investors held iShares Evolved U.S. Innovative Healthcare ETF (IEIH) as of Q4 2018, up from 1 in Q3 2018.
  • Funds reported $3.18M of iShares Evolved U.S. Innovative Healthcare ETF stock for Q4 2018, down 23% quarter-over-quarter.
  • 1 fund opened new iShares Evolved U.S. Innovative Healthcare ETF positions in Q4 2018 and 0 closed out, a net change of +1 holder.
  • The largest iShares Evolved U.S. Innovative Healthcare ETF buyer in Q4 2018 was Fidelity Investments, an estimated $25 added.
  • The largest iShares Evolved U.S. Innovative Healthcare ETF seller in Q4 2018 was BlackRock, an estimated $377K sold.

Based on aggregated 13F filings for Q4 2018.